Guardant Health, Inc.
GH
$129.69
-$3.53-2.65%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -4.00% | 4.61% | 22.17% | 15.68% | 9.62% |
| Total Depreciation and Amortization | -7.08% | -6.25% | -6.22% | -4.42% | -3.09% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 13.62% | -4.08% | -11.23% | 23.85% | 112.73% |
| Change in Net Operating Assets | 84.40% | 76.29% | -906.77% | -689.06% | -311.63% |
| Cash from Operations | 31.06% | 22.97% | 12.27% | 15.05% | 3.05% |
| Capital Expenditure | -51.57% | -37.68% | -93.88% | -79.75% | -63.90% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -365.15% | -129.82% | -20.44% | -95.74% | -93.69% |
| Cash from Investing | -1,809.77% | -140.02% | -26.36% | -99.16% | -98.10% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 2,373.14% | 2,446.22% | -81.97% | -85.53% | -96.94% |
| Repurchase of Common Stock | 52.19% | -381.76% | -628.06% | -625.03% | -535.38% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -246.59% | -18,592.81% | -484.87% | -137.27% | 49.28% |
| Cash from Financing | 1,172.91% | 67,482.83% | -169.00% | -171.62% | -113.99% |
| Foreign Exchange rate Adjustments | -437.59% | 127.74% | -154.24% | 230.18% | 107.48% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 191.45% | 72.15% | -99.50% | -139.23% | -135.93% |